Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Akcea Therapeutics, Inc. is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 26.2% downward over the last 30 days.
Civeo Corporation (CVEO - Free Report) is a provider of hospitality services. The Zacks Consensus Estimate for its current year earnings has been revised 11.1% downward over the last 30 days.
Clarivate Analytics Plc is an information services and analytics company. The Zacks Consensus Estimate for its current year earnings has been revised 20.8% downward over the last 30 days.
Covetrus, Inc. is an animal-health technology and services company. The Zacks Consensus Estimate for its current year earnings has been revised 7.5% downward over the last 30 days.
Dorman Products, Inc. (DORM - Free Report) is a supplier of replacement parts and fasteners for passenger cars and other vehicles. The Zacks Consensus Estimate for its current year earnings has been revised 9.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Akcea Therapeutics, Inc. is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 26.2% downward over the last 30 days.
Civeo Corporation (CVEO - Free Report) is a provider of hospitality services. The Zacks Consensus Estimate for its current year earnings has been revised 11.1% downward over the last 30 days.
Clarivate Analytics Plc is an information services and analytics company. The Zacks Consensus Estimate for its current year earnings has been revised 20.8% downward over the last 30 days.
Covetrus, Inc. is an animal-health technology and services company. The Zacks Consensus Estimate for its current year earnings has been revised 7.5% downward over the last 30 days.
Dorman Products, Inc. (DORM - Free Report) is a supplier of replacement parts and fasteners for passenger cars and other vehicles. The Zacks Consensus Estimate for its current year earnings has been revised 9.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on DORM - FREE
Get the latest research report on CVEO - FREE